Benjamin Pratt (4 out of 15 patents)
Raju Mohan (4 out of 77 patents)
Company Badge
USPTO Data Jan 1 1976 - Oct 20 2026
4 Patents
#172 in Cambridge
#3,872 in United Kingdom
Akarna Therapeutics, Ltd.
Forward Citations = 23
2 inventors:
Akarna Therapeutics, Ltd.
EPO Patents = 2
Forward Citations = 23
Loading Chart...
Loading Chart...
2 inventors (with patents filed for the assignee):
4 patents:
Company Overview
Akarna Therapeutics, Ltd. is a clinical-stage biopharmaceutical company focused on the development of novel small molecule therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) and other liver diseases. The company's lead candidate, AKN-083, is a potent FXR agonist that has demonstrated promising results in preclinical studies. Akarna is dedicated to providing innovative treatment options for patients with liver diseases.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Akarna Therapeutics, Ltd.. Retrieved from https://idiyas.com/company/akarna-therapeutics
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
2 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]